Basic Information
AstriVax NV, established in 2022, aims to address global vaccine challenges through its innovative plug-and-play vaccine platform. The company has developed novel preventive and therapeutic vaccines that are easy to produce, reduce cold chain requirements, and provide broad and long-lasting protection against various infectious diseases.
AstriVax NV
Vlaams Brabant,Flemishregion,Belgium
15~50 people
January 01, 2022
info@astrivax.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios